Targeting HIV-1 through molecular modeling and docking studies of CXCR4: Leads for therapeutic development

被引：19

作者：

Singh, Shailza ^{[1
]}

Malik, B. K.

Sharma, D. K.

机构：

[1] Indian Inst Technol, Ctr Energy Studies, New Delhi 110016, India

[2] CSIR, Inst Genom & Integrat Biol, New Delhi 110007, India

来源：

CHEMICAL BIOLOGY & DRUG DESIGN | 2007年 / 69卷 / 03期

关键词：

CXCR4; docking; flavonoids; human immunodeficiency virus; molecular modeling; AIDS-RELATED-COMPLEX; ENTRY INHIBITORS; ANTIRETROVIRAL THERAPY; CHEMOKINE RECEPTORS; AZIDOTHYMIDINE AZT; PROTEIN-STRUCTURE; CD4; RECEPTOR; DOUBLE-BLIND; MIP-1; ALPHA; VIRUS;

D O I：

10.1111/j.1747-0285.2007.00478.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The chemokine receptor CXCR4 is the receptor for several chemokines and major co-receptor for X4 human immunodeficiency virus type-1 strains entry into cell. A three-dimensional model of human CXCR4 was developed by homology modeling using the high-resolution bovine rhodopsin structure as template. Interactions between CXCR4 and flavonoids were investigated using in silico docking studies. The results underscore the potential of these compounds that they may become important new antiviral drugs to combat AIDS. It is worth mentioning also that apart from these existing flavonoids, there are many new compounds that may also be useful as topical agents to inactivate virus, or may act as adjuvants with other antiviral drugs.

引用

页码：191 / 203

页数：13

共 50 条

[21] Hologram Quantitative Structure Activity Relationship, Docking, and Molecular Dynamics Studies of Inhibitors for CXCR4
Zhang, Chongqian
Du, Chunmiao
Feng, Zhiwei
Zhu, Jingyu
Li, Youyong
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (02) : 119 - 136
[22] Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
Ito, Shigeki
Sato, Tsuyoshi
Maeta, Takahiro
CANCERS, 2021, 13 (08)
[23] Marked structural and functional heterogeneity in CXCR4:: Separation of HIV-1 and SDF-Iα responses
Sloane, AJ
Raso, V
Dimitrov, DS
Xiao, XD
Deo, S
Muljadi, N
Restuccia, D
Turville, S
Kearney, C
Broder, CC
Zoellner, H
Cunningham, AL
Bendall, L
Lynch, GW
IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (02) : 129 - 143
[24] HIV-1 Utilizes the CXCR4 Chemokine Receptor to Infect Multipotent Hematopoietic Stem and Progenitor Cells
Carter, Christoph C.
McNamara, Lucy A.
Onafuwa-Nuga, Adewunmi
Shackleton, Mark
Riddell, James
Bixby, Dale
Savona, Michael R.
Morrison, Sean J.
Collins, Kathleen L.
CELL HOST & MICROBE, 2011, 9 (03) : 223 - 234
[25] CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2
Hoxie, JA
LaBranche, CC
Endres, MJ
Turner, JD
Berson, JF
Doms, RW
Matthews, TJ
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 41 (1-2) : 197 - 211
[26] A Functionally Selective Synthetic Mimic of the HIV-1 Co-receptor CXCR4
Moebius, Kalle
Duerr, Ralf
Haussner, Christina
Dietrich, Ursula
Eichler, Jutta
CHEMISTRY-A EUROPEAN JOURNAL, 2012, 18 (27) : 8292 - 8295
[27] Plectlin regulates the signaling and trafficking of the HIV-1 co-receptor CXCR4 and plays a role in HIV-1 infection
Ding, Yun
Zhang, Li
Goodwin, J. Shawn
Wang, Ziqing
Liu, Bingdong
Zhang, Jingwu
Fan, Guo-Huang
EXPERIMENTAL CELL RESEARCH, 2008, 314 (03) : 590 - 602
[28] Development of pyridine dicoumarols as potent anti HIV-1 leads, targeting HIV-1 associated topoisomeraseIIβ kinase
Kammari, Kurumurthy
Devaraya, Kiran
Bommakanti, Akhila
Kondapi, Anand K.
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (14) : 1597 - 1609
[29] HIV-1 Nef promotes migration and chemokine synthesis of human basophils and mast cells through the interaction with CXCR4
Rossi F.W.
Prevete N.
Rivellese F.
Lobasso A.
Napolitano F.
Granata F.
Selleri C.
De Paulis A.
Clinical and Molecular Allergy, 14 (1)
[30] Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection
Wilkinson, Royce A.
Pincus, Seth H.
Song, Kejing
Shepard, Joyce B.
Weaver, Alan J., Jr.
Labib, Mohamed E.
Teintze, Martin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 2197 - 2201

← 1 2 3 4 5 →